Randomized Study of Digital Life Coaching in Myeloma Patients Undergoing Transplantation

Verified

Overview

This study will investigate whether peri-stem cell transplant digital life coaching can lower benzodiazepine and Z-class drugs usage (for anxiety and insomnia) and improve patient-reported well-being.

SparkCures ID 1243
Trial Phase Phase 1
Enrollment 60 Patients
Trial Sponsors
  • UCSF Helen Diller Comprehensive Cancer Center
Trial Collaborators
  • American Society of Clinical Oncology
NCT Identifier

NCT04589286

CLOSED

This trial has completed.

Am I Eligible?

The following criteria is a partial list of reasons why patients may or may not be eligible to participate in this clinical trial. Further evaluation with a medical professional will be required to determine full eligibility.

The following criteria is provided for health care professionals.

Inclusion Criteria:

  • Confirmed diagnosis of one of the following (all referred to as multiple myeloma (MM) for the purposes of this protocol):
    • Multiple myeloma (ICD-10 code: C90.0)
    • Extramedullary plasmacytoma (ICD-10 code: C90.2)
  • Planned receipt of autologous stem cell transplantation (SCT) at University of California, San Francisco (UCSF)
  • Patients undergoing outpatient SCT will be eligible
  • Patients who received chemomobilization will be eligible
  • Ability to understand a written informed consent form (ICF) document, and the willingness to sign the ICF document

Exclusion Criteria:

  • Age < 18 years
  • SCT as salvage therapy
  • Patient-assessed lack of sufficient English proficiency
  • Lack of ownership of a personal smartphone

US Trial Locations

Please visit the ClinicalTrials.gov page for historical site information.

View Centers
SparkCures Verified

SparkCures is working closely with UCSF Helen Diller Comprehensive Cancer Center to provide the most up-to-date information on this clinical trial. Use the button above to add this trial to your list of favorites.

Learn more about how we work with trial sponsors